We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

96 hedge funds and large institutions have $234M invested in Autolus Therapeutics in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 24 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

398% more call options, than puts

Call options by funds: $488K | Put options by funds: $98K

42% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 24

17% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 12

2% more funds holding

Funds holding: 94 → 96 (+2)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

8% less ownership

Funds ownership: 62.39% → 54.39% (-8%)

38% less capital invested

Capital invested by funds: $379M → $234M (-$145M)

Holders
96
Holders Change
+2
Holders Change %
+2.13%
% of All Funds
1.26%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
14
Increased
34
Reduced
24
Closed
12
Calls
$488K
Puts
$98K
Net Calls
+$390K
Net Calls Change
+$437K

Top Buyers

Rank Fund Capital Flow
1
MCO
MAK Capital One
New York
+$17.7M
2
Citadel Advisors
Citadel Advisors
Florida
+$9.85M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$9.43M
4
AC
Armistice Capital
New York
+$7.03M
5
Renaissance Technologies
Renaissance Technologies
New York
+$6.12M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$61.9M
2
DTC
Deep Track Capital
Connecticut
-$27.9M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.2M
4
Axa
Axa
France
-$7.13M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$6.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$669K +$111K +56,995 +16%
Millennium Management
27
Millennium Management
New York
$639K +$765K +391,833 New
QC
28
Quadrature Capital
United Kingdom
$582K +$510K +261,047 +271%
PFM
29
Privium Fund Management
Netherlands
$503K +$28.7K +14,695 +5%
EAM
30
EdenTree Asset Management
United Kingdom
$486K – – –
XT
31
XTX Topco
Cayman Islands
$419K +$174K +89,107 +53%
DC
32
Diametric Capital
Massachusetts
$419K -$43.9K -22,456 -8%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$384K +$29.8K +15,259 +7%
Wells Fargo
34
Wells Fargo
California
$377K -$42.9K -21,970 -9%
ACM
35
Aubrey Capital Management
United Kingdom
$375K -$425K -217,746 -48%
HF
36
HRT Financial
New York
$342K +$411K +210,172 New
Tudor Investment Corp
37
Tudor Investment Corp
Connecticut
$337K +$195K +100,000 +94%
EAM
38
Erste Asset Management
Austria
$310K – – –
DCM
39
DAFNA Capital Management
California
$292K -$481K -246,300 -58%
Two Sigma Investments
40
Two Sigma Investments
New York
$281K +$49.5K +25,346 +17%
Geode Capital Management
41
Geode Capital Management
Massachusetts
$268K – – –
CSS
42
Cubist Systematic Strategies
Connecticut
$260K +$101K +51,650 +48%
GCM
43
Graham Capital Management
Connecticut
$241K +$289K +147,877 New
LPL Financial
44
LPL Financial
California
$218K +$196K +100,400 +299%
Ohio Public Employees Retirement System (OPERS)
45
Ohio Public Employees Retirement System (OPERS)
Ohio
$216K +$259K +132,688 New
AA
46
ALPS Advisors
Colorado
$203K -$37.1K -19,008 -13%
HP
47
HealthInvest Partners
Sweden
$202K +$125K +64,173 +6%
CA
48
Clearstead Advisors
Ohio
$197K – – –
NIM
49
NEOS Investment Management
Connecticut
$189K -$8.92K -4,565 -4%
TE
50
Tema ETFs
New York
$189K -$8.92K -4,565 -4%
1
2
3 4 5

AUTL Hedge Fund Activity: Q3 2025 in Review

96 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q3 2025, worth a combined $234M — down 38% from $379M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new AUTL positions and 12 closed out — a net gain of 2 holders — while 34 added to existing stakes and 24 trimmed.

The largest buyer was MAK Capital One, adding an estimated $17.7M. The largest seller was Wellington Management Group, exiting entirely with an estimated $61.9M sold.

  • 96 institutional investors held Autolus Therapeutics (AUTL) as of Q3 2025, up from 94 in Q2 2025.
  • Funds reported $234M of Autolus Therapeutics stock for Q3 2025, down 38% quarter-over-quarter.
  • 14 funds opened new Autolus Therapeutics positions in Q3 2025 and 12 closed out, a net change of +2 holders.
  • The largest Autolus Therapeutics buyer in Q3 2025 was MAK Capital One, an estimated $17.7M added.
  • The largest Autolus Therapeutics seller in Q3 2025 was Wellington Management Group, an estimated $61.9M sold.

Based on aggregated 13F filings for Q3 2025.